For: | Al-Dhamin Z, Liu LD, Li DD, Zhang SY, Dong SM, Nan YM. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies. World J Gastroenterol 2020; 26(47): 7444-7469 [PMID: 33384547 DOI: 10.3748/wjg.v26.i47.7444] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i47/7444.htm |
Number | Citing Articles |
1 |
Zerui Wang, Tiantian Li, Ziying Zhang, Mengqi Yuan, Ming Shi, Fu-Sheng Wang, En-Qiang Linghu, Lei Shi. Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol. BMJ Open 2023; 13(12): e078362 doi: 10.1136/bmjopen-2023-078362
|
2 |
Kate Da Silva, Pradeep Kumar, Yahya E. Choonara. The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives. Wound Repair and Regeneration 2025; 33(1) doi: 10.1111/wrr.13251
|
3 |
Ahmed Elzainy, Abir El Sadik, Waleed Mohammad Altowayan. Comparison between the Regenerative and Therapeutic Impacts of Bone Marrow Mesenchymal Stem Cells and Adipose Mesenchymal Stem Cells Pre-Treated with Melatonin on Liver Fibrosis. Biomolecules 2024; 14(3): 297 doi: 10.3390/biom14030297
|
4 |
Doha El-Sayed Ellakwa, Seham Mohamed Saied El Nakeeb, Sawsan Ahmed Abd El Mohsen. The impact of hydrogen sulfide on mesenchymal stem cells in rats suffering from liver fibrosis via suppression of TGF-β signaling. Gene Reports 2024; 37: 102056 doi: 10.1016/j.genrep.2024.102056
|
5 |
Fatemeh Askari Yazdian, Matin Mojaveri Samak, Amirhossein Larijani, Mohammad Taghi Ashoobi, Mohadese Kharaqani, Mohammad Amin Ghezel, Zahra Barabadi, Elham Vojoudi. From Cells to Exosomes: a Review of Non-Surgical Biotherapeutic-Based Strategies for Liver Regeneration in the Face of End-Stage Diseases. Stem Cell Reviews and Reports 2025; doi: 10.1007/s12015-025-10872-1
|
6 |
D. V. Garbuzenko. Current strategies for targeted therapy of liver fibrosis. Bulletin of Siberian Medicine 2022; 21(3): 154 doi: 10.20538/1682-0363-2022-3-154-165
|
7 |
Simona-Rebeca Nazarie (Ignat), Sami Gharbia, Anca Hermenean, Sorina Dinescu, Marieta Costache. Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies. International Journal of Molecular Sciences 2021; 22(24): 13292 doi: 10.3390/ijms222413292
|
8 |
Asmaa R. Ellakany, Hanan El Baz, Zeinab S. Shoheib, Mohamed Elzallat, Dalia S. Ashour, Nabila A. Yassen. Stem cell-derived exosomes as a potential therapy for schistosomal hepatic fibrosis in experimental animals. Pathogens and Global Health 2024; 118(5): 429 doi: 10.1080/20477724.2023.2240085
|
9 |
Yunlong Shan, Mengying Zhang, Enxiang Tao, Jing Wang, Ning Wei, Yi Lu, Qing Liu, Kun Hao, Fang Zhou, Guangji Wang. Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01936-8
|
10 |
Shouli Yuan, Meng Dong, Hanlin Zhang, Xiaoxiao Jiang, Chunlong Yan, Rongcai Ye, Huiqiao Zhou, Li Chen, Huiru Lian, Wanzhu Jin. Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGFβR1. International Journal of Biological Macromolecules 2022; 194: 556 doi: 10.1016/j.ijbiomac.2021.11.098
|
11 |
Nathaly Enciso, José Amiel, Fredy Fabián-Domínguez, Jhon Pando, Nancy Rojas, Carlos Cisneros-Huamaní, Ernesto Nava, Javier Enciso, Ulises Urzua. Model of Liver Fibrosis Induction by Thioacetamide in Rats for Regenerative Therapy Studies. Analytical Cellular Pathology 2022; 2022: 1 doi: 10.1155/2022/2841894
|
12 |
María Martín-López, Cristina Rosell-Valle, Blanca Arribas-Arribas, Beatriz Fernández-Muñoz, Rosario Jiménez, Sonia Nogueras, Ana Belén García-Delgado, Fernando Campos, Mónica Santos-González. Bioengineered tissue and cell therapy products are efficiently cryopreserved with pathogen-inactivated human platelet lysate-based solutions. Stem Cell Research & Therapy 2023; 14(1) doi: 10.1186/s13287-023-03300-z
|
13 |
Jun Liu, Feila Liu, Tingting Liang, Yue Zhou, Xiaohan Su, Xue Li, Jiao Zeng, Peng Qu, Yali Wang, Fuli Chen, Qian Lei, Gang Li, Panke Cheng. The roles of Th cells in myocardial infarction. Cell Death Discovery 2024; 10(1) doi: 10.1038/s41420-024-02064-6
|
14 |
Abeer Kazmi, Tahira Sultana. Advances in mesenchymal stem cell therapy and natural antioxidants for hepatic fibrosis: A comprehensive review. Pharmacological Research - Reports 2024; 2: 100016 doi: 10.1016/j.prerep.2024.100016
|
15 |
Jiejuan Lai, Shifang Jiang, Ling Shuai, Yujun Zhang, Renpei Xia, Quanyu Chen, Lianhua Bai. Comparison of the biological and functional characteristics of mesenchymal stem cells from intrahepatic and identical bone marrow. Stem Cell Research 2021; 55: 102477 doi: 10.1016/j.scr.2021.102477
|
16 |
Zhenyu Liu, Junkai Ren, Cheng Qiu, Ying Wang, Tong Zhang. Application of mesenchymal stem cells in liver fibrosis and regeneration. Liver Research 2024; 8(4): 246 doi: 10.1016/j.livres.2024.11.004
|
17 |
Shouli Yuan, Meng Dong, Hanlin Zhang, Hongde Xu, Qi Wang, Chunlong Yan, Rongcai Ye, Xiaoxiao Jiang, Huiqiao Zhou, Li Chen, Jun Cheng, Wen Xie, Wanzhu Jin. Oral delivery of a Lactococcus lactis expressing extracellular TGFβR2 alleviates hepatic fibrosis. Applied Microbiology and Biotechnology 2021; 105(14-15): 6007 doi: 10.1007/s00253-021-11485-7
|
18 |
Liang Liu, Yanling Zhou, Xuchen Dong, Suwen Li, Shan Cheng, Haoran Li, Yongdong Li, Jiaqi Yuan, Liping Wang, Jun Dong, Xiaodong Li. HOTAIRM1 Maintained the Malignant Phenotype of tMSCs Transformed by GSCs via E2F7 by Binding to FUS. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/7734413
|